openPR Logo
Press release

US FDA Prohibits 19 Antibacterial Soap Ingredients

01-23-2017 01:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: SGS

/ PR Agency: Sugarloaf Marketing

The US Food and Drug Administration (FDA) has issued a final rule regarding 19 ingredients in over-the-counter (OTC) consumer antiseptic products intended for use with water. The FDA has now determined that these 19 ingredients are not generally recognized as safe and effective (GRAS/GRAE) and so, without an approved new drug application, products containing these ingredients are now considered misbranded – effective September 6, 2017.

The US FDA issued its final rule on the Safety and Effectiveness of Antibacterial Soaps on September 2, 2016, following a request for manufacturers to submit additional information on the safety and effectiveness of antibacterial soaps, issued on December 16, 2013. The final rule was issued when no additional data was received, or the data submitted was not sufficient to support the monograph conditions for the 19 ingredients.

This ruling prohibits the use of the following ingredients:
• Cloflucarban
• Fluorosalan
• Hexachlorophene
• Hexylresorcinol
• Iodophors (Iodine-containing ingredients)
• Iodine complex (ammonium ether sulfate and polyoxyethylene sorbitan monolaurate)
- Iodine complex (phosphate ester of alkylaryloxy polyethylene glycol)
- Nonylphenoxypoly (ethyleneoxy) ethanoliodine
- Poloxamer—iodine complex
- Povidone-iodine 5 to 10 percent
- Undecoylium chloride iodine complex
• Methylbenzethonium chloride
• Phenol (greater than 1.5 percent)
• Phenol (less than 1.5 percent)
• Secondary amyltricresols
• Sodium oxychlorosene
• Tribromsalan
• Triclocarban
• Triclosan
• Triple dye

The US FDA has deferred rulemaking on a further three substances, used in OTC consumer antiseptic wash products, to allow more time for the submission of new safety and effectiveness data. These active ingredients are: Benzalkonium chloride, Benzethonium chloride and Chloroxylenol. Products containing these ingredients can continue to be marketed while the data is collected.

SGS Cosmetic Regulation Services
It is crucial that all cosmetic, personal care and household products are safe, effective and stable. SGS provides testing, inspection, auditing and consulting services to manufacturers, distributors and importers to ensure a high level of product quality in every area. Our state of the art laboratories provide custom-made solutions for chemical, biophysical, microbiological, stability and biological aspects. We also have extensive capabilities in performance testing, claim support studies and consumer panels. Our testing is conducted according to customer specific or recognized standard methods, some of which were developed by SGS. Our cosmetic safety assessors and other technical experts can support customers by making sure new products comply with regulatory requirements.
Learn more about SGS’s Cosmetic Regulation Services (www.sgs.com/en/consumer-goods-retail/cosmetics-personal-care-and-household/cosmetics-and-personal-care/regulations)

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full Final Rule on Safety and Effectiveness of Antibacterial Soaps Issued by the US FDA SafeGuardS. (www.sgs.com/en/news/2016/09/safeguards-15516-final-rule-on-safety-and-effectiveness-of-antibacterial-soaps]

Subscribe here, www.sgs.com/subscribesg, to receive SGS SafeGuardS direct to your inbox.

For further information contact:

Queenie Tse
Technical Service Executive
Cosmetics, Personal Care and Household (CPCH)
Tel: +852 2765 3672 (ext 1672)
Email: cts.media@sgs.com
Website: www.sgs.com/cpch

About SGS
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 85,000 employees, SGS operates a network of over 1,800 offices and laboratories around the world.

1, Mons Calpe
Chitcombe Road
Broad Oak
Rye
East Sussex
TN31 6EU

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US FDA Prohibits 19 Antibacterial Soap Ingredients here

News-ID: 419291 • Views:

More Releases from SGS

SGS Summarizes Impact of EU Postponement of RED Cybersecurity Regulation Enforce …
SGS, the world's leading testing, inspection and certification company, has published SafeGuardS 095.23 to help stakeholders understand the impact of the decision to postpone the enforcement of the Radio Equipment Directive (RED) delegated act for cybersecurity until 2025. The European Commission (EC) originally planned to enforce the delegated act from August 2024. However, delays in the preparation of harmonized standards have meant the EC has now taken the decision to enforce
SGS Issues SafeGuardS for US CPSC Direct Final Rule for Bedside Sleepers
SGS, the world's leading testing, inspection and certification company, has published a SafeGuardS covering a recent direct final rule for bedside sleepers issued by the US Consumer Products Safety Commission (CPSC). Direct final rule 16 CFR 1222 was published on May 9, 2023, revising the safety standard for bedside sleepers. It incorporates the latest version of ASTM F2906-23 (Standard Consumer Safety Specification for Bedside Sleepers) with a modification. The modification involves
SGS Announces Complementary Webinar to Help Businesses Navigate Post-Brexit European Requirements for PPE
SGS Announces Complementary Webinar to Help Businesses Navigate Post-Brexit Euro …
SGS, the world's leading testing, inspection and certification company, has announced a webinar to help companies operating in European personal protective equipment (PPE) markets understand the implications of Brexit and the best route towards compliance. "Personal Protective Equipment: overview of EU and UK requirements" will be offered in two sessions on February 9, 2023, at 10.00 CET and 16.00 CET. It is aimed at operators throughout the PPE value chain, including
Patented pest management products now available direct from manufacturer
01-11-2023 | Energy & Environment
SGS
Patented pest management products now available direct from manufacturer
In 2023, IPS is taking a new pathway in the distribution of the company's flagship products. It is now possible to purchase the CLTab and SPTab solutions under the Insectrac brand name directly from IPS, the manufacturer. The company behind these unique products is International Pheromone Systems a customer-orientated company with 35 years of experience in developing, producing, and supplying high-quality insect pheromone and kairomone formulations and associated trapping systems to a

All 5 Releases


More Releases for FDA

FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
Peyronie’s Disease Market - Only FDA approved product
The market is dominated by a single player, Endo International plc who sells the only FDA approved Peyronie’s disease product. In May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex. Furthermore, the company is creating awareness through its “Ask About the Curve” campaign. Also, reimbursement from the U.S. insurance providers will boost the demand for this product. The product
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
11-09-2016 | Science & Education
GRCTS
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding